Abstract: The present disclosure provides a flexible printed circuit board (FPCB), a method for manufacturing the FPCB, and a capacitive touch display device with the FPCB. The FPCB comprises an FPCB substrate and a common electrode voltage (VCOM) filter circuit arranged on the FPCB substrate. The FPCB further includes one or more filter units. the filter units comprises: a conduction layer, arranged on the FPCB substrate and electrically connected to a VCOM output end of the VCOM filter circuit; an isolation layer, arranged on the conduction layer; and a shielding film, which is grounded, arranged on the isolation layer and arranged parallel with the conduction layer.

Abstract: A method for preparing a synthetic rubber, including a step of graft-polymerizing a main polymer with a methyl-methacrylate monomer in the presence of a peroxide initiator of formula (I): R1—O—O—R2, wherein each of R1 and R2 is independently an alkyl group or an alkanoyl group including from 1 to 30 carbon atoms.

Abstract: An array substrate, a method for fabricating the same, a display device and a drive method thereof are disclosed. In the array substrate, a pixel data storage circuit and a R/W control circuits for controlling the pixel data storage circuits are formed within a display region of the array substrate and read/write is realized by a R/W data line and a R/W control line extending into a non-display region of the array substrate. It can thereby avoid arranging GRAM in the data drive circuit, so as to reduce the size of the data drive circuit, which is beneficial to the light-weighting and thinning of the display device.

Abstract: The present disclosure relates to a field of fabrication of liquid crystal display, and more particularly, provides a gate driving circuit, an array substrate, a display device and a driving method. For the problem that TSP signal acquisition of each frame is scanned at a fixed time such that dark lines might appear as viewed by human eyes, the present disclosure provides delay shift modules in at least two different positions, and controls whether they operate or not by a switch control module, an effect of staggering a predetermined time for which a panel suspends operation between adjacent frames is achieved. The present disclosure can stagger the predetermined time for which the touch screen panel suspends operation within adjacent odd and even frames, so as to solve the problem of the dark lines as viewed by human eyes.

Abstract: The present disclosure relates to a field of fabrication of liquid crystal display, and more particularly, provides a gate driving circuit, an array substrate, a display device and a driving method. For the problem that TSP signal acquisition of each frame is scanned at a fixed time such that dark lines might appear as viewed by human eyes, the present disclosure provides delay shift modules in at least two different positions, and controls whether they operate or not by a switch control module, an effect of staggering a predetermined time for which a panel suspends operation between adjacent frames is achieved. The present disclosure can stagger the predetermined time for which the touch screen panel suspends operation within adjacent odd and even frames, so as to solve the problem of the dark lines as viewed by human eyes.

Abstract: The present disclosure provides a flexible printed circuit board (FPCB), a method for manufacturing the FPCB, and a capacitive touch display device with the FPCB. The FPCB comprises an FPCB substrate and a common electrode voltage (VCOM) filter circuit arranged on the FPCB substrate. The FPCB further includes one or more filter units. the filter units comprises: a conduction layer, arranged on the FPCB substrate and electrically connected to a VCOM output end of the VCOM filter circuit; an isolation layer, arranged on the conduction layer; and a shielding film, which is grounded, arranged on the isolation layer and arranged parallel with the conduction layer.

Abstract: The present invention relates to a otitis media diagnosis system using terahertz electromagnetic waves, which can diagnose otitis media using terahertz electromagnetic waves in a non-invasive manner, and which can accurately diagnose otitis media by acquiring images on the tympanic cavity using terahertz electromagnetic waves with excellent transmittance, and which can quickly and accurately divide exudative otitis media and suppurative otitis media using terahertz electromagnetic waves that are sensitive to moisture, and which is safe to a body using terahertz electromagnetic waves. The otitis media diagnosis system includes a terahertz probe including a generating unit for radiating terahertz electromagnetic waves from the outside of an ear toward a tympanic cavity and a detection unit for detecting the reflected terahertz electromagnetic waves reflected from the tympanic cavity.

Abstract: This invention relates to a vaccine for preventing or treating tautopathy, comprising a vector, as an active ingredient, comprising a nucleic acid encoding a mutant tau protein linked to a secretion signal sequence, wherein the vaccine is capable of inducing an antibody against an (optionally phospholylated) tau protein in a subject in a more sustained manner compared with a case where the mutant tau protein is administered directly.

Abstract: A pixel circuit, an organic electroluminescent display panel and a display device are provided. The pixel circuit includes a luminous device (D1), a photosensitive device (P1), a drive control sub-module (1), a data write sub-module (2), a light-emitting control sub-module (3) and a touch detection sub-module (4). Upon the data write sub-module (2) being turned on, a data signal at the data signal terminal (Data) is transmitted to the drive control sub-module (1) by the data write sub-module (2). Upon the light-emitting control sub-module (3) being turned on, the light-emitting control sub-module (3) controls the drive control sub-module (1) to drive the luminous device (D1) to give off light, so as to achieve a display function. Upon the touch detection sub-module (4) being turned on, the touch detection sub-module (4) controls output of a touch detection signal from the drive control sub-module (1) to a touch signal read terminal.

Abstract: The invention discloses an array substrate and a driving method thereof, and a display device, and the array substrate includes: a common voltage generation unit, a timing control unit, a data voltage generation unit, a switch control unit and pixel units, wherein the switch control unit is connected to the common voltage generation unit, the timing control unit, the data voltage generation unit, the common voltage line and the data line, and the switch control unit is used to load a common voltage signal on the common voltage line and load a data voltage signal on the data line when a current frame of image is displayed, and load the common voltage signal on the data line and load the data voltage signal on the common voltage line when a next frame of image is displayed.

Abstract: A pixel circuit, an organic electroluminescent display panel and a display device are provided. The pixel circuit includes a luminous device (D1), a photosensitive device (P1), a drive control sub-module (1), a data write sub-module (2), a light-emitting control sub-module (3) and a touch detection sub-module (4). Upon the data write sub-module (2) being turned on, a data signal at the data signal terminal (Data) is transmitted to the drive control sub-module (1) by the data write sub-module (2). Upon the light-emitting control sub-module (3) being turned on, the light-emitting control sub-module (3) controls the drive control sub-module (1) to drive the luminous device (D1) to give off light, so as to achieve a display function. Upon the touch detection sub-module (4) being turned on, the touch detection sub-module (4) controls output of a touch detection signal from the drive control sub-module (1) to a touch signal read terminal.

Abstract: This invention relates to a vaccine for preventing or treating tautopathy, comprising a vector, as an active ingredient, comprising a nucleic acid encoding a mutant tau protein linked to a secretion signal sequence, wherein the vaccine is capable of inducing an antibody against an (optionally phospholylated) tau protein in a subject in a more sustained manner compared with a case where the mutant tau protein is administered directly.

Abstract: This invention relates to a vaccine for preventing or treating tautopathy, comprising a vector, as an active ingredient, comprising a nucleic acid encoding a mutant tau protein linked to a secretion signal sequence, wherein the vaccine is capable of inducing an antibody against an (optionally phosphorylated) tau protein in a subject in a more sustained manner compared with a case where the mutant tau protein is administered directly.

Abstract: The present invention relates to a otitis media diagnosis system using terahertz electromagnetic waves, which can diagnose otitis media using terahertz electromagnetic waves in a non-invasive manner, and which can accurately diagnose otitis media by acquiring images on the tympanic cavity using terahertz electromagnetic waves with excellent transmittance, and which can quickly and accurately divide exudative otitis media and suppurative otitis media using terahertz electromagnetic waves that are sensitive to moisture, and which is safe to a body using terahertz electromagnetic waves. The otitis media diagnosis system includes a terahertz probe including a generating unit for radiating terahertz electromagnetic waves from the outside of an ear toward a tympanic cavity and a detection unit for detecting the reflected terahertz electromagnetic waves reflected from the tympanic cavity.

Abstract: This invention relates to a vaccine for preventing or treating tautopathy, comprising a vector, as an active ingredient, comprising a nucleic acid encoding a mutant tau protein linked to a secretion signal sequence, wherein the vaccine is capable of inducing an antibody against an (optionally phosphorylated) tau protein in a subject in a more sustained manner compared with a case where the mutant tau protein is administered directly.

Abstract: The present invention relate to a method for monitoring a response to a therapy on a mammal having a neurodegenerative or neuroinflammatory disorder. According to a preferred embodiment, the method comprising the steps of: a) imaging the mammal using a radio-labeled peripheral benzodiazepine receptor ligand; b) administrating in the mammal at least one anti-amyloid or anti-neuroinflammatory agent; c) imaging the mammal of step b) using a radio-labeled peripheral benzodiazepine receptor ligand; and d) detecting the level of CNS neuroinflammation by the signals from the radio-labeled peripheral benzodiazepine receptor ligand.

Abstract: Computer processing of order data received at a computer system in connection with the sale and purchase of debt instruments in a primary market includes automatically adjusting an order size based on a investor-specified demand curve for a debt instrument and a market value that established subsequent to the receipt of the purchase order. The demand quantity can be specified by a collection of discrete data sets, each including a market value and a demand quantity at that market value. A dynamically updated order book that aggregates the received orders to distinguish demand for the debt instrument at different market values can be displayed to an issuer and used to establish the market value of the debt instrument. The order book may be updated upon request during a subscription period for the debt instrument to enable access to an updated status of orders placed for the issue. Purchases may be automatically transacted using swaps to satisfy payment obligations for received allocations of the new issue.